Skip to content
★ Sign in to follow
MY

Michael Yurkowsky

Board Director
Director
H-Cyte, Inc.
Total declarations
10
Company
1
▲ Purchases (6 ops.)
€7,281
▼ Sales (0 ops.)
—

Latest filing published 01 Jul 2021 for H-CYTE, INC., €2,890.

Filing timeline

BuySale
Michael Yurkowsky

Insider track record

Disclosed buys
6
Disclosed sells
0
Signal history

Closed purchases

Market purchases
6

Not enough history yet: 1 closed purchase, at least 2 are needed.

Purchases by company

Since each purchase

  • Filed 21 Jan 2020 · 2483 days ago · €230
    -67.9%
    Entry US$170.00 · Close at T+365 US$54.50

Entry is the close on the day after publication, the first price a reader could act on. Prices in the listing currency. Past moves are not a forecast.

Michael Yurkowsky: trading record in brief

Michael Yurkowsky, listed as board member, appears in our data through filings on H-Cyte, Inc. shares, published by SEC (Form 4). Over a trading history stretching from 16 December 2019 to 29 June 2021, the count stands at 10 filings.

On the market, this insider has only ever bought: 6 purchases, €7,281 in total. Open-market purchases are the filings investors watch most closely, because the insider pays for the shares out of pocket.

Half of the purchases are above €841 and half below.

The newest entry dates from 1 July 2021: a transaction of €2,890, in H-Cyte, Inc. The clock since the last published purchase (21 January 2020) now reads 2,483 days. Between a trade and the moment it shows up on SEC (Form 4), the median delay is 4 days. For comparison, the SEC allows two business days to file a Form 4. Every figure here comes from the filings published by SEC (Form 4) and describes the past, not future prices; it is not investment advice.

Companies and markets linked to Michael Yurkowsky

Open company profiles for insider transactions, fundamentals and analyst consensus when available.

Declarations10 total
  • ●
    DirectorExecutivesH-Cyte, Inc.
    3,440 USD0SEC
    21,500 shares@ US$0.16Common stockSEC:0001493152-21-015897:1
  • ●
    DirectorExecutivesH-Cyte, Inc.
    950 USD0SEC
    5,000 shares@ US$0.19Common stockSEC:0001493152-21-015897:2
  • ●
    DirectorExecutivesH-Cyte, Inc.
    1,000 USD0SEC
    5,000 shares@ US$0.20Common stockSEC:0001493152-21-015897:3
  • ●
    DirectorExecutivesH-Cyte, Inc.
    6,460 USD19SEC
    38,000 shares@ US$0.17100.0% of flowCommon stockSEC:0001493152-21-015897:0
  • ▲
    DirectorExecutivesH-Cyte, Inc.
    1,048 USD0SEC
    8,100 shares@ US$0.1294Common StockSEC:0001493152-20-000822:0
    Canonical exit: 16 Apr 2020 (T+90)
  • ▲
    DirectorExecutivesH-Cyte, Inc.
    675 USD0SEC
    5,000 shares@ US$0.135Common StockSEC:0001493152-20-000822:1
    Canonical exit: 16 Apr 2020 (T+90)
  • ▲
    DirectorExecutivesH-Cyte, Inc.
    1,450 USD0SEC
    10,000 shares@ US$0.145Common StockSEC:0001493152-20-000822:3
    Canonical exit: 16 Apr 2020 (T+90)
  • ▲
    DirectorExecutivesH-Cyte, Inc.
    256 USD11SEC
    1,900 shares@ US$0.13480.0% of flowCommon StockSEC:0001493152-20-000822:2
    Canonical exit: 16 Apr 2020 (T+90)
  • ▲
    DirectorExecutivesH-Cyte, Inc.
    3,850 USD0SEC
    27,500 shares@ US$0.14Common StockSEC:0001493152-19-019561:0
    Canonical exit: 15 Mar 2020 (T+90)
  • ▲
    DirectorExecutivesH-Cyte, Inc.
    825 USD0SEC
    7,500 shares@ US$0.11Common StockSEC:0001493152-19-019561:1
    Canonical exit: 15 Mar 2020 (T+90)

10 of 10 declarations